Fate Therapeutics Target Price

Where could FATE trade next? Consensus target price: $5.6.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.34

Average Target Price

$5.63

140.4% upside

4 analysts in the last 4 months

High: $8 | Low: $3.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-14	Piper Sandler	$8	241.9% upside
2026-08-14	Wells Fargo	$3.5	49.6% upside
2026-06-08	H.C. WainwrightDebjit Chattopadhyay	$7	199.1% upside
2026-05-19	Jefferies	$4	70.9% upside
2025-03-06	Stifel Nicolaus	$3	28.2% upside
2024-11-13	BMO CapitalEtzer Darout	$5	113.7% upside
2024-08-14	Stifel NicolausBenjamin Burnett	$5	113.7% upside
2024-06-17	Piper SandlerEdward Tenthoff	$6	156.4% upside
2024-05-16	H.C. WainwrightDebjit Chattopadhyay	$5	113.7% upside
2024-05-10	Piper SandlerEdward Tenthoff	$4	70.9% upside
2024-05-10	BMO CapitalEtzer Darout	$6	156.4% upside
2024-05-10	Canaccord GenuityBill Maughan	$9	284.6% upside
2023-01-09	Goldman Sachs	$4	70.9% upside
2023-01-06	Morgan Stanley	$8	241.9% upside
2023-01-06	Piper Sandler	$12	412.8% upside
2023-01-06	BMO Capital	$7	199.1% upside
2023-01-05	Truist FinancialRobyn Karnauskas	$7	199.1% upside
2022-12-15	Goldman SachsAndrea Tan	$10	327.4% upside
2022-12-13	Truist Financial	$46	1865.8% upside
2021-12-13	OppenheimerMatthew Biegler	$135	5669.2% upside
2021-11-08	CitigroupYigal Nochomovitz	$87	3617.9% upside
2021-11-05	Roth CapitalAnthony Butler	$60	2464.1% upside
2021-10-25	JefferiesMichael Yee	$145	6096.6% upside
2021-08-20	Piper SandlerEdward Tenthoff	$113	4729.1% upside

Fate Therapeutics (FATE) FAQ

The latest target price for FATE is $5.6. Investors often review this figure alongside Fate Therapeutics's historical trend and sector peers before judging valuation or financial health.

Fate Therapeutics trades near $2.34 while the consensus target sits at $5.6 (140.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting FATE's target price ($5.6), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Fate Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.